Your browser doesn't support javascript.
loading
Development of heterocyclic-based frameworks as potential scaffold of 5-HT1A receptor agonist and future perspectives: A review.
Yuan, Weihua; Ma, Yanyan; Zhang, Hui.
Afiliação
  • Yuan W; School of Acupuncture-Moxibustion and Tuina, Anhui University of Chinese Medicine, Hefei, China.
  • Ma Y; Gumei Community Health Service Centre, Shanghai Medical College of Fudan University, Shanghai, China.
  • Zhang H; School of Acupuncture-Moxibustion and Tuina, Anhui University of Chinese Medicine, Hefei, China.
Medicine (Baltimore) ; 103(24): e38496, 2024 Jun 14.
Article em En | MEDLINE | ID: mdl-38875413
ABSTRACT
As a subtype of the 5-hydroxytryptamine (5-HT) receptor, 5-HT1A receptors are involved in the pathological process of psychiatric disorders and is an important target for antidepressants. The research groups focus on these area have tried to design novel compounds to alleviate depression by targeting 5-HT1A receptor. The heterocyclic structures is an important scaffold to enhance the antidepressant activity of ligands, including piperazine, piperidine, benzothiazole, and pyrrolidone. The current review highlights the function and significance of nitrogen-based heterocyclics 5-HT1AR represented by piperazine, piperidine, benzothiazole, and pyrrolidone in the development of antidepressant.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptor 5-HT1A de Serotonina / Agonistas do Receptor 5-HT1 de Serotonina / Antidepressivos Limite: Humans Idioma: En Revista: Medicine (Baltimore) Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptor 5-HT1A de Serotonina / Agonistas do Receptor 5-HT1 de Serotonina / Antidepressivos Limite: Humans Idioma: En Revista: Medicine (Baltimore) Ano de publicação: 2024 Tipo de documento: Article